praziquantel has been researched along with Bile Duct Cancer in 22 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| "The liver fluke, Opisthorchis viverrini, and the associated incidence of subsequent cholangiocarcinoma (CCA) are still a public health problem in Thailand, and praziquantel (PZQ) remains the antihelminthic drug of choice for treatment." | 8.89 | Association between praziquantel and cholangiocarcinoma in patients infected with Opisthorchis viverrini: a systematic review and meta-analysis. ( Bhudhisawasdi, V; Kamsa-ard, S; Laopaiboon, M; Luvira, V, 2013) |
| " Recently, we demonstrated a persistent APF in over one-third of opisthorchiasis patients after worm removal by praziquantel (PZQ) treatment." | 8.12 | Persistent advanced periductal fibrosis is associated with cagA-positive Helicobacter pylori infection in post-praziquantel treatment of opisthorchiasis. ( Deenonpoe, R; Edwards, SW; Mairiang, E; Phung, HTT; Sripa, B; Suttiprapa, S, 2022) |
| "It has been suggested that repeated infection of Opisthorchis viverrini followed by repeated treatment with praziquantel (PZQ) increases risk of development of cholangiocarcinoma (CCA)." | 7.85 | Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model. ( Brindley, PJ; Hanpanich, P; Laha, T; Mairiang, E; Sereerak, P; Sripa, B; Tangkawattana, P; Tangkawattana, S; Upontain, S, 2017) |
| " Aspirin has many properties including anti-inflammation and anti-cancer." | 7.83 | Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma. ( Aukkanimart, R; Boonmars, T; Jiraporn, S; Loilome, W; Nadchanan, W; Namwat, N; Ruangjirachuporn, W; Sriraj, P; Sudsarn, P, 2016) |
| " There was a statistically significant dose-response relationship (p < 0." | 5.42 | Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study. ( Bhudhisawasdi, V; Kamsa-Ard, S; Luvira, V; Pugkhem, A; Suwanrungruang, K; Thinkhamrop, B, 2015) |
| "The liver fluke, Opisthorchis viverrini, and the associated incidence of subsequent cholangiocarcinoma (CCA) are still a public health problem in Thailand, and praziquantel (PZQ) remains the antihelminthic drug of choice for treatment." | 4.89 | Association between praziquantel and cholangiocarcinoma in patients infected with Opisthorchis viverrini: a systematic review and meta-analysis. ( Bhudhisawasdi, V; Kamsa-ard, S; Laopaiboon, M; Luvira, V, 2013) |
| " Recently, we demonstrated a persistent APF in over one-third of opisthorchiasis patients after worm removal by praziquantel (PZQ) treatment." | 4.12 | Persistent advanced periductal fibrosis is associated with cagA-positive Helicobacter pylori infection in post-praziquantel treatment of opisthorchiasis. ( Deenonpoe, R; Edwards, SW; Mairiang, E; Phung, HTT; Sripa, B; Suttiprapa, S, 2022) |
| "It has been suggested that repeated infection of Opisthorchis viverrini followed by repeated treatment with praziquantel (PZQ) increases risk of development of cholangiocarcinoma (CCA)." | 3.85 | Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model. ( Brindley, PJ; Hanpanich, P; Laha, T; Mairiang, E; Sereerak, P; Sripa, B; Tangkawattana, P; Tangkawattana, S; Upontain, S, 2017) |
| " Aspirin has many properties including anti-inflammation and anti-cancer." | 3.83 | Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma. ( Aukkanimart, R; Boonmars, T; Jiraporn, S; Loilome, W; Nadchanan, W; Namwat, N; Ruangjirachuporn, W; Sriraj, P; Sudsarn, P, 2016) |
| " Treatment of opisthorchiasis patients with praziquantel, an anti- trematode drug was shown to reduce inflammation-mediated tissue damage and carcinogenesis." | 3.78 | Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. ( Bartsch, H; Pinlaor, S; Yongvanit, P, 2012) |
| "Praziquantel is the treatment of choice and has been considered for preventive chemotherapy." | 2.53 | Clonorchiasis. ( Keiser, J; Qian, MB; Utzinger, J; Zhou, XN, 2016) |
| " Those dose-response relationship was statistically significant based on chi-square test for trend (p-value <0." | 1.72 | Association between the Number of Repeated Praziquantel Treatments and Kidney Parenchymal Change in Northeast Thailand. ( Chamadol, N; Kelly, M; Khuntikeo, N; Prathumkam, P; Thinkhamrop, B; Thinkhamrop, K; Thuanman, J, 2022) |
| "Opisthorchis viverrini infection is highly prevalent in northeast Thailand." | 1.51 | Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand. ( Gray, DJ; Kelly, MJ; Khuntikeo, N; Sithithaworn, P; Suwannatrai, AT; Thinkhamrop, K; Thinkhamrop, W; Wangdi, K, 2019) |
| " Since many people are aware that dosing with praziquantel (PZQ) is a successful treatment for an episode of the infection, there is a risk that, to avoid the long term consequences, they will engage in a cycle of infection, dosing and reinfection." | 1.43 | Reinfection by Opisthorchis Viverrini after Treatment with Praziquantel. ( Bradshaw, P; Promthet, S; Saengsawang, P, 2016) |
| " There was a statistically significant dose-response relationship (p < 0." | 1.42 | Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study. ( Bhudhisawasdi, V; Kamsa-Ard, S; Luvira, V; Pugkhem, A; Suwanrungruang, K; Thinkhamrop, B, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 13 (59.09) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Phung, HTT | 1 |
| Deenonpoe, R | 2 |
| Suttiprapa, S | 1 |
| Mairiang, E | 5 |
| Edwards, SW | 1 |
| Sripa, B | 4 |
| Prathumkam, P | 1 |
| Thinkhamrop, K | 2 |
| Khuntikeo, N | 3 |
| Chamadol, N | 2 |
| Thuanman, J | 1 |
| Kelly, M | 1 |
| Thinkhamrop, B | 2 |
| Luvira, V | 5 |
| Kamsa-Ard, S | 4 |
| Srisuk, T | 1 |
| Pugkhem, A | 2 |
| Pairojkul, C | 3 |
| Bhudhisawasdi, V | 3 |
| Sithithaworn, P | 6 |
| Thinkhamrop, W | 1 |
| Wangdi, K | 1 |
| Kelly, MJ | 1 |
| Suwannatrai, AT | 1 |
| Gray, DJ | 1 |
| Wonkchalee, N | 1 |
| Boonmars, T | 2 |
| Laummaunwai, P | 1 |
| Aromdee, C | 1 |
| Hahnvajanawong, C | 1 |
| Wu, Z | 1 |
| Sriraj, P | 2 |
| Aukkanimart, R | 2 |
| Chamgramol, Y | 2 |
| Juasook, A | 1 |
| Sudsarn, P | 2 |
| Laopaiboon, M | 1 |
| Chomvarin, C | 1 |
| Loukas, A | 1 |
| Brindley, PJ | 2 |
| Ruangjirachuporn, W | 1 |
| Namwat, N | 1 |
| Loilome, W | 1 |
| Nadchanan, W | 1 |
| Jiraporn, S | 1 |
| Qian, MB | 1 |
| Utzinger, J | 1 |
| Keiser, J | 1 |
| Zhou, XN | 1 |
| Suwanrungruang, K | 1 |
| Saengsawang, P | 1 |
| Promthet, S | 1 |
| Bradshaw, P | 1 |
| Hanpanich, P | 1 |
| Laha, T | 1 |
| Sereerak, P | 1 |
| Upontain, S | 1 |
| Tangkawattana, P | 1 |
| Tangkawattana, S | 1 |
| Dechakhamphu, S | 2 |
| Yongvanit, P | 7 |
| Nair, J | 2 |
| Pinlaor, S | 5 |
| Sitthithaworn, P | 2 |
| Bartsch, H | 3 |
| Oh, JH | 1 |
| Kim, HG | 1 |
| Hiraku, Y | 2 |
| Tada-Oikawa, S | 1 |
| Ma, N | 1 |
| Pinlaor, P | 1 |
| Murata, M | 2 |
| Oikawa, S | 2 |
| Kawanishi, S | 2 |
| Thanan, R | 1 |
| Tangkanakul, W | 1 |
| Haswell-Elkins, MR | 3 |
| Satarug, S | 2 |
| Tsuda, M | 2 |
| Esumi, H | 2 |
| Mairiang, P | 3 |
| Saitoh, M | 1 |
| Elkins, DB | 3 |
| Fukunaga, K | 1 |
| Nozue, M | 1 |
| Moon, Y | 1 |
| Monoi, H | 1 |
| Yamamoto, Y | 1 |
| Osada, A | 1 |
| Kawamoto, T | 1 |
| Koike, N | 1 |
| Fukao, K | 1 |
| Sukprasert, S | 1 |
| Chaiyakum, J | 1 |
| Loapaiboon, V | 1 |
2 reviews available for praziquantel and Bile Duct Cancer
| Article | Year |
|---|---|
Association between praziquantel and cholangiocarcinoma in patients infected with Opisthorchis viverrini: a systematic review and meta-analysis.
Topics: Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Humans; O | 2013 |
Clonorchiasis.
Topics: Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Clonorchi | 2016 |
20 other studies available for praziquantel and Bile Duct Cancer
| Article | Year |
|---|---|
Persistent advanced periductal fibrosis is associated with cagA-positive Helicobacter pylori infection in post-praziquantel treatment of opisthorchiasis.
Topics: Antigens, Bacterial; Bacterial Proteins; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Fibrosis; Fo | 2022 |
Association between the Number of Repeated Praziquantel Treatments and Kidney Parenchymal Change in Northeast Thailand.
Topics: Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Female; Humans; Kidney; Male; | 2022 |
Association between Repeated Praziquantel treatment and Papillary, and Intrahepatic Cholangiocarcinoma.
Topics: Anthelmintics; Bile Duct Neoplasms; Biopsy; Carcinoma, Papillary; Case-Control Studies; Cholangiocar | 2018 |
Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Bile Duct Neoplasms; Cholangiocarcinoma; Cro | 2019 |
A combination of praziquantel and the traditional medicinal plant Thunbergia laurifolia on Opisthorchis viverrini infection and cholangiocarcinoma in a hamster model.
Topics: Acanthaceae; Alanine Transaminase; Alkaline Phosphatase; Animals; Anthelmintics; Anti-Inflammatory A | 2013 |
The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter.
Topics: Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cricetina | 2015 |
Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.
Topics: Animals; Anthelmintics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bile Duct Neoplasms; Bile | 2016 |
Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study.
Topics: Adult; Aged; Anthelmintics; Bile Duct Neoplasms; Case-Control Studies; Cholangiocarcinoma; Fasciolia | 2015 |
Reinfection by Opisthorchis Viverrini after Treatment with Praziquantel.
Topics: Adult; Aged; Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcino | 2016 |
Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model.
Topics: Animals; Anthelmintics; Bile Duct Neoplasms; Carcinogenesis; Cholangiocarcinoma; Cricetinae; Humans; | 2017 |
High excretion of etheno adducts in liver fluke-infected patients: protection by praziquantel against DNA damage.
Topics: Adult; Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Ch | 2008 |
Lipid peroxidation and etheno DNA adducts in white blood cells of liver fluke-infected patients: protection by plasma alpha-tocopherol and praziquantel.
Topics: alpha-Tocopherol; Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangioca | 2010 |
[A case of clonorchiasis presenting as common bile duct mass].
Topics: Aged, 80 and over; Animals; Anthelmintics; Bile Duct Neoplasms; Cholangiopancreatography, Endoscopic | 2010 |
Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis.
Topics: Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cyclooxyg | 2012 |
iNOS-dependent DNA damage via NF-kappaB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antihelminthic drug praziquantel.
Topics: Animals; Anthelmintics; Anticarcinogenic Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Blot | 2006 |
Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Analysis of Variance; Animals; Anthelmintics; Bile Duct Neoplasms; Bile | 2008 |
Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis.
Topics: Adult; Animals; Bile Duct Neoplasms; Cholangiocarcinoma; Cross-Sectional Studies; Diet; Humans; Male | 1994 |
[Cholangiocarcinoma at the hepatic hilus with clonorchiasis].
Topics: Adenoma, Bile Duct; Bile Duct Neoplasms; Clonorchiasis; Female; Humans; Liver Diseases, Parasitic; M | 1993 |
Thiocyanate-independent nitrosation in humans with carcinogenic parasite infection.
Topics: Adult; Analysis of Variance; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Huma | 1996 |
Cross-sectional patterns of hepatobiliary abnormalities and possible precursor conditions of cholangiocarcinoma associated with Opisthorchis viverrini infection in humans.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholelithiasis; Cross-Sect | 1996 |